EMDB-70909:
Heteromeric GluA1/A2 in the inactive state, consensus refinement of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70910:
Heteromeric GluA1/A2 in the inactive state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70911:
Heteromeric GluA1/A2 in the inactive state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70912:
Heteromeric GluA1/A2 in the inactive state, composite map of LBD-TMD
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

EMDB-70913:
Heteromeric GluA1/A2 in the activated state, consensus refinement of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70914:
Heteromeric GluA1/A2 in the activated state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70915:
Heteromeric GluA1/A2 in the activated state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70916:
Heteromeric GluA1/A2-CNIH1 in the activated state, consensus refinement of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70917:
Heteromeric GluA1/A2-CNIH1 in the activated state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70918:
Heteromeric GluA1/A2-CNIH1 in the activated state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70919:
Composite map of GluA1/A2 in the activated state, in complex with positive allosteric modulator (R,R)-2b and agonist glutamate (ATD-LBD-TMD)
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

EMDB-70920:
Heteromeric GluA1/A2-CNIH1 in the activated state, composite map of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70921:
Heteromeric GluA1/A2 in the desensitized state, consensus refinement of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70922:
Heteromeric GluA1/A2 in the desensitized state, amino-terminal domain (ATD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70923:
Heteromeric GluA1/A2 in the desensitized state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70924:
Heteromeric GluA1/A2 in the desensitized state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70925:
Heteromeric GluA1/A2 in the desensitized state, composite map of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-75274:
Heteromeric GluA1/A2 in the activated state, amino-terminal domain (ATD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-48892:
Ligand-binding and transmembrane domains for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49067:
Consensus map for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49073:
Consensus map for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48894:
Ligand-binding and transmembrane domains for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48882:
Amino-terminal domain for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49071:
Consensus map for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48884:
Ligand-binding and transmembrane domains for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48885:
Amino-terminal domain for GluK2-0xNeto2 in the apo state with asymmetric ligand binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48886:
Ligand-binding and transmembrane domains for GluK2-0xNeto2 in the apo state with asymmetric ligand binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48893:
Amino-terminal domain for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49068:
Consensus map for GluK2-0xNeto2 in the apo state with asymmetric ligand-binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48895:
Amino-terminal domain for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48896:
Ligand-binding and transmembrane domains for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48891:
Amino-terminal domain for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49072:
Consensus map for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-47792:
Structure of full length AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 in complex with anti-miR 17 oligonucleotide RGLS4326
Method: single particle / : Yen LY, Gangwar SP, Yelshanskaya MV, Sobolevsky AI

EMDB-47793:
Structure of AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 (LBD-TMD) in complex with anti-miR 17 oligonucleotide RGLS4326
Method: single particle / : Yen LY, Gangwar SP, Yelshanskaya MV, Sobolevsky AI

EMDB-48888:
Ligand-binding and transmembrane domains for GluK2-1xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48890:
Ligand-binding and transmembrane domains for GluK2-2xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49070:
Consensus map for GluK2-2xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48889:
Amino-terminal domain for GluK2-2xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48887:
Amino-terminal domain for GluK2-1xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-49069:
Consensus map for GluK2-1xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48897:
Composite map for GluK2 in the apo state with asymmetric ligand binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48898:
Composite map for GluK2 in the apo state with 2-fold symmetrical ligand-binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48899:
Composite map for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48900:
Composite map for GluK2-0xNeto2 in the apo state with asymmetric ligand-binding domain
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48901:
Composite map for GluK2-1xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48902:
Composite map for GluK2-2xNeto2 in the apo state
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48903:
Composite map for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48904:
Composite map for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI

EMDB-48905:
Composite map for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate
Method: single particle / : Gangwar SP, Yelshanskaya MV, Yen LY, Newton TP, Sobolevsky AI